Bellecapital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,065	Closed	-$446K	–	131
2025 Q3	$446K	Sell	16,065 -13,659	-46%	-$345K	0.07%	78
2025 Q2	$724K	Sell	29,724 -8,267	-22%	-$181K	0.13%	66
2025 Q1	$789K	Sell	37,991 -272	-0.7%	-$6.83K	0.16%	64
2024 Q4	$901K	Sell	38,263 -35,320	-48%	-$869K	0.16%	63
2024 Q3	$1.88M	Sell	73,583 -1,250	-2%	-$31.8K	0.37%	46
2024 Q2	$1.76M	Buy	74,833 +10,100	+16%	+$255K	0.37%	47
2024 Q1	$1.86M	Buy	64,733 +3,091	+5%	+$93K	0.41%	47
2023 Q4	$2.02M	Sell	61,642 -11,889	-16%	-$323K	0.46%	47
2023 Q3	$2.05M	Buy	73,531 +1,084	+1%	+$35.4K	0.51%	46
2023 Q2	$2.47M	Buy	72,447 +8,724	+14%	+$274K	0.6%	45
2023 Q1	$1.92M	Buy	63,723 +5,380	+9%	+$167K	0.48%	46
2022 Q4	$1.65M	Sell	58,343 -17,192	-23%	-$546K	0.46%	46
2022 Q3	$2.48M	Buy	75,535 +3,981	+6%	+$146K	0.76%	37
2022 Q2	$2.25M	Sell	71,554 -17,312	-19%	-$605K	0.63%	44
2022 Q1	$4.08M	Buy	88,866 +13,961	+19%	+$666K	1.29%	23
2021 Q4	$4.59M	Buy	74,905 +321	+0.4%	+$22.2K	1.31%	24
2021 Q3	$5.57M	Buy	74,584 +6,876	+10%	+$577K	1.7%	19
2021 Q2	$6.26M	Sell	67,708 -7,303	-10%	-$621K	1.9%	16
2021 Q1	$6.66M	Sell	75,011 -15,506	-17%	-$1.54M	2.08%	15
2020 Q4	$8.44M	Buy	+90,517	New	+$7.21M	2.82%	5